Sangadala Sreedhara, Boden Scott D, Metpally Raghu Prasad Rao, Reddy Boojala Vijay B
Atlanta VA Medical Center and the Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia 30329, USA.
Proteins. 2007 Aug 15;68(3):690-701. doi: 10.1002/prot.21429.
LIM Mineralization Protein-1 (LMP-1) has been cloned and shown to be osteoinductive. Our efforts to understand the mode of action of LMP-1 led to the determination that LMP-1 interacts with Smad Ubiquitin Regulatory Factor-1 (Smurf1). Smurf1 targets osteogenic Smads, Smad1/5, for ubiquitin-mediated proteasomal degradation. Smurf1 interaction with LMP-1 or Smads is based on the presence of unique WW-domain interacting motif in these target molecules. By performing site-directed mutagenesis and binding studies in vitro on purified recombinant proteins, we identified a specific motif within the osteogenic region of several LMP isoforms that is necessary for Smurf1 interaction. Similarly, we have identified that the WW2 domain of Smurf1 is necessary for target protein interaction. Here, we present a homology-based modeling of the Smurf1 WW2 domain and its interacting motif of LMP-1. We performed computational docking of the interacting domains in Smurf1 and LMPs to identify the key amino acid residues involved in their binding regions. In support of the computational predictions, we also present biochemical evidence supporting the hypothesis that the physical interaction of Smurf1 and osteoinductive forms of LMP may prevent Smurf1 from targeting osteogenic Smads by ubiquitin-mediated proteasomal degradation.
LIM矿化蛋白-1(LMP-1)已被克隆并显示具有骨诱导性。我们为了解LMP-1作用模式所做的努力,确定了LMP-1与Smad泛素调节因子-1(Smurf1)相互作用。Smurf1将成骨Smads,即Smad1/5,靶向进行泛素介导的蛋白酶体降解。Smurf1与LMP-1或Smads的相互作用基于这些靶分子中独特的WW结构域相互作用基序的存在。通过对纯化的重组蛋白进行体外定点诱变和结合研究,我们在几种LMP同工型的成骨区域内鉴定出一个对Smurf1相互作用必不可少的特定基序。同样,我们已经确定Smurf1的WW2结构域对于靶蛋白相互作用是必需的。在此,我们展示了基于同源性的Smurf1 WW2结构域及其与LMP-1相互作用基序的建模。我们对Smurf1和LMPs中的相互作用结构域进行了计算对接,以识别其结合区域中涉及的关键氨基酸残基。为支持计算预测结果,我们还提供了生化证据,支持以下假设:Smurf1与骨诱导形式的LMP的物理相互作用可能会阻止Smurf1通过泛素介导的蛋白酶体降解靶向成骨Smads。